Home
Subscription
December 2024 issue
November 2024 issue
October 2024 issue
September 2024 issue
August 2024 issue
July 2024 issue
June 2024 issue
May 2024 issue
April 2024 issue
April 1, 2024 issue
March 2024 issue
February 2024 issue
January 2024 issue
BACK ISSUES
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
|
2016 Issues
December 2016 Issue
• Peace and Good Will
• New Drug Review: Lixisenatide (Adlyxin – Sanofi)
• Appreciation
• Index for Volume 11, 2016
November 2016 Issue
• Feature: You Say Adherence and I Say Compliance – Whatever We Call It, Pharmacists, with Our Patients, Must Respond to this Challenge!
• New Drug Review: Lifitegrast (Xiidra – Shire)
October 2016 Issue
• Feature: Understanding and Reducing Drug Prices Must Start with Transparency
• New Drug Review: Insulin degludec (Tresiba – Novo Nordisk)
September 2016 Issue
• Feature: Our Profession and Our Patients Need Independent Pharmacists! But Can We Keep Them?
August 2016 Issue
• Feature: The PBM Formulary Follies
• New Drug Review: Pimavanserin tartrate (Nuplazid – Acadia)
July 2016 Issue
• Feature: CVS has an Exceptional Opportunity but Rejects It – To the Peril of its Customers and Frustration and Risk of its Pharmacists!
• New Drug Review: Brivaracetam (Briviact – UCB)
June 2016 Issue
• Feature: Physician-Assisted Suicide - Can we not care best for our patients by walking with them in the dying instead of leading them to it?
• New Therapeutic Agents Marketed in the United States in 2015
May 2016 Issue
• Feature: OUTRAGES! – But Some With Opportunities!
• New Drug Review: Lesinurad (Zurampic – AstraZeneca; Ironwood)
April 2016 Issue
• Feature: The FDA Should Provide Pharmacists with the Authority to Dispense Chantix Without a Prescription
• New Drug Review: Cariprazine hydrochloride (Vraylar – Allergan)
March 2016 Issue
• Feature: Prescription Drug Prices – Billions for Pharmaceutical Companies, Insurance Companies, and PBMs, but Pennies for Pharmacies
• New Drug Review: Eluxadoline (Viberzi – Allergan)
February 2016 Issue
• Feature: Is Walgreens Valeant's New Philidor?
• New Drug Review: Mepolizumab (Nucala – GlaxoSmithKline)
January 2016 Issue
• Feature: Pharmacy Must Have a More Effective Organizational Structure! - The United Pharmacists of America
• New Drug Review: Ledipasvir/sofosbuvir (Harvoni – Gilead Sciences)
• New Drug Review: Secukinumab (Cosentyx – Novartis)
| |
